Zobrazeno 1 - 10
of 424
pro vyhledávání: ''
Autor:
Johan Maertens, Hélène Labussière-Wallet, Yener Koc, Mohamad Mohty, Giorgia Battipaglia, Didier Blaise, Myriam Labopin, Fabio Ciceri, Anne Huynh, Armin Gerbitz, Hakan Ozdogu, Franciane Paul, Eolia Brissot, Ali Bazarbachi, Rose-Marie Hamladji, Mahmoud Aljurf, Jan J. Cornelissen, Bipin N. Savani, Arnon Nagler, Ellen Meijer, Patrice Chevallier, Annalisa Ruggeri, Boris V. Afanasyev, Gérard Socié
Publikováno v:
Cancer
Cancer, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Cancer, Wiley, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Battipaglia, G, Labopin, M, Hamladji, R-M, Blaise, D, Chevallier, P, Brissot, E, Gerbitz, A, Socié, G, Afanasyev, B, Ciceri, F, Meijer, E, Koc, Y, Cornelissen, J J, Huynh, A, Ozdogu, H, Maertens, J, Paul, F, Labussière-Wallet, H L, Ruggeri, A, Aljurf, M, Bazarbachi, A, Savani, B, Nagler, A & Mohty, M 2021, ' Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation ', Cancer, vol. 127, no. 2, pp. 209-218 . https://doi.org/10.1002/cncr.33255
Cancer, 127(2), 209-218. John Wiley and Sons Inc.
Cancer, 127(2), 209-218. John Wiley & Sons Inc.
Cancer, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Cancer, Wiley, 2021, 127 (2), pp.209-218. ⟨10.1002/cncr.33255⟩
Battipaglia, G, Labopin, M, Hamladji, R-M, Blaise, D, Chevallier, P, Brissot, E, Gerbitz, A, Socié, G, Afanasyev, B, Ciceri, F, Meijer, E, Koc, Y, Cornelissen, J J, Huynh, A, Ozdogu, H, Maertens, J, Paul, F, Labussière-Wallet, H L, Ruggeri, A, Aljurf, M, Bazarbachi, A, Savani, B, Nagler, A & Mohty, M 2021, ' Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation ', Cancer, vol. 127, no. 2, pp. 209-218 . https://doi.org/10.1002/cncr.33255
Cancer, 127(2), 209-218. John Wiley and Sons Inc.
Cancer, 127(2), 209-218. John Wiley & Sons Inc.
International audience; Background: Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Addition of antithymocyte globulin (ATG) or post-transplantation cyclophosphamide (PTCY
Autor:
Emily Curran, Amy Wang, Michaela Liedtke, Aniko Szabo, Ryan J. Mattison, Madelyn Burkart, Caitlin Siebenaller, Ehab Atallah, Anand Patel, Jay Yang, Muhammad Ali Khan, Martha Wadleigh, Rory M. Shallis, Shukaib Arslan, Suresh Kumar Balasubramanian, Mehrdad Hefazi, Shira Dinner, Nikolai A. Podoltsev, Mark R. Litzow, Anjali S. Advani, Talha Badar, Ilana R. Yurkiewicz, Eric Kuo, Ibrahim Aldoss
Publikováno v:
Cancer. 127:1039-1048
Background The availability of novel agents (NAs), including blinatumomab and inotuzumab ozogamicin (InO), has improved the outcomes of patients with relapsed/refractory (RR) B-cell acute lymphoblastic leukemia (ALL). Because of the relative effectiv
Autor:
Alois Gratwohl, Jason Law, David Szwajcer, Jean A. Yared, Bronwen E. Shaw, Ruta Brazauskas, Amer Beitinjaneh, Matthew L. Ulrickson, Hisham Abdel-Azim, Sara Beattie, Navneet S. Majhail, Shahrukh K. Hashmi, J. Douglas Rizzo, Wael Saber, Neel S. Bhatt, William A. Wood, Charles F. LeMaistre, Stephanie J. Lee, Bipin N. Savani, Sherif M. Badawy, Stefan O. Ciurea, Richard F. Olsson, David A. Rizzieri, Hasan Hashem, Sachiko Seo, Sanghee Hong, Jan Cerny, Akshay Sharma, Kyle Hebert, Hélène Schoemans, Hillard M. Lazarus, Ayami Yoshimi, Rammurti T. Kamble, Siddhartha Ganguly, Nosha Farhadfar, Theresa Hahn, Miguel Angel Diaz, Nandita Khera, Mahmoud Aljurf, Usama Gergis
Publikováno v:
Cancer
Cancer, vol 127, iss 4
Cancer, vol 127, iss 4
Background The association of community factors and outcomes after hematopoietic cell transplantation (HCT) has not been comprehensively described. Using the County Health Rankings and Roadmaps (CHRR) and the Center for International Blood and Marrow
Autor:
Wenli Liu, Renata Ferrarotto, Aiham Qdaisat, Larissa A. Meyer, Clifton D. Fuller, Ehab Y. Hanna, Lorenzo Cohen, Santhosshi Narayanan, Sai Ching J. Yeung, Eduardo Bruera, Gabriel Lopez, Ming Guo
Publikováno v:
Cancer
BACKGROUND: Prior research has confirmed that persistent hypomagnesemia was predictive of shorter survival among patients with ovarian cancer who received carboplatin-based chemotherapy. In the current retrospective study, the authors examined the as
Autor:
Doris Augustin, Rachel Wuerstlein, Henriette Christgen, Toralf Reimer, Nadia Harbeck, Bahriye Aktas, Ronald E. Kates, Benno Nuding, Marianne Just, Petra Krabisch, Wolfram Malter, Oleg Gluz, Monika Graeser, Michael R. Clemens, Sherko Kuemmel, Andrea Stefek, Matthias Christgen, Frederick L. Baehner, Mieke Raap, Hans Kreipe, Ulrike Nitz
Publikováno v:
Cancer. 126:4847-4858
BACKGROUND Invasive lobular breast cancer (BC) is the second most common BC subtype. Prognostic parameters (tumor classification, lymph node status, histologic grade, Oncotype DX recurrence score [RS], progesterone receptor status, and Ki67 index) we
Autor:
Frank C.S. Wong, Roger Kai Cheong Ngan, Ashley A. C. Cheng, Wai Tong Ng, Harry H.Y. Yiu, Rick Chappell, Stewart Y. Tung, Anthony T.C. Chan, Taixiang Lu, Kam-Tong Yuen, Anne W.M. Lee, Horace C.W. Choi, Henry C.K. Sze, Dora L.W. Kwong
Publikováno v:
Cancer. 126:3674-3688
Background A current recommendation for the treatment of patients with locoregionally advanced nasopharyngeal carcinoma (NPC) is conventional fractionated radiotherapy (RT) with concurrent cisplatin followed by adjuvant cisplatin and 5-fluorouracil (
Autor:
Xavier Leleu, Jean-Claude Chomel, André Herbelin, Carine Motard, Stéphanie Ragot, Florence Tartarin, Anne Corby, Guillaume Denis, Jose Torregrosa-Diaz, Deborah Desmier, Thomas Systchenko, Lydia Roy, Jean-Marc Gombert, Emmanuel Fleck, Emilie Cayssials, Pilar Gallego-Hernanz, François Guilhot, Antoine Machet, Natacha Maillard
Publikováno v:
Cancer. 126:3438-3447
Background Long-term treatment-free remission (TFR) represents a new goal for chronic myeloid leukemia (CML). In clinical practice, tyrosine kinase inhibitor (TKI) dose reductions can be considered a means of preventing adverse effects and improving
Publikováno v:
Cancer. 126:3244-3254
BACKGROUND The role of arsenic trioxide (As2 O3 ) in the maintenance of first complete remission (CR1) in acute promyelocytic leukemia (APL) is unclear. METHODS A total of 129 consecutive adult patients with APL of all risk categories who achieved CR
Autor:
Valerae O. Lewis, Alexander J. Lazar, Bryan S. Moon, Maria Alejandra Zarzour, Christina L. Roland, Ravin Ratan, Andrew J. Bishop, B. Ashleigh Guadagnolo, Barry W. Feig, Wei Lien Wang, Keila E. Torres, Jace P. Landry
Publikováno v:
Cancer
OBJECTIVE: To evaluate treatment outcomes in patients with desmoid tumors (DT) receiving local therapy with surgery alone, radiation therapy (RT) alone, or combined modality RT and surgery (CMT). METHODS: We performed a cross-sectional cohort study o
Publikováno v:
Cancer
BACKGROUND With the increasing use of multigene panel tests, pathogenic and likely pathogenic (P/LP) variants are identified more frequently in the moderate-penetrance breast cancer genes ATM and CHEK2. Lifetime breast cancer risk among women with P/